Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545168 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
A Phase 3 study, sponsored by ParaPRO.
- Completed
- Registry status
- Phase 3
- Development phase
- 480
- Enrollment target
NCT00545168 is a Phase 3 study that has completed, run by ParaPRO. The registered enrollment target is 480 participants.
The verdict
NCT00545168, a Phase 3 study, has completed, sponsored by ParaPRO.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 480 participants
- Enrollment target
Study Summary
A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (Head lice).
Interventions
- DRUG Permethrin 1%
- DRUG Spinosad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00545168
The ClinicalTrials.gov registry entry for NCT00545168 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ParaPRO, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Permethrin 1% is the first listed.
NCT00545168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00545168 about?
NCT00545168 is a clinical study titled "Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice". A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (Head lice).
What is the current status of trial NCT00545168?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2007-09. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00545168?
The interventions under investigation include: Permethrin 1% (DRUG), Spinosad (DRUG).
Who is sponsoring clinical trial NCT00545168?
This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.